Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryo Yamada

Showing results (1-10 of 254) with videos related to

Pageof 26
Sort By:
Autoimmunity Reviews|May 17, 2005
Peptidylarginine deiminase type 4, anticitrullinated peptide antibodies, and rheumatoid arthritisRyo Yamada
Clinical Calcium|October 30, 2012
[Genomic approach to pathophysiology of rheumatoid arthritis]Ryo Yamada
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 1, 2005
[Susceptibility genes in rheumatoid arthritis: peptidylarginine deiminase (PADI) type 4]Ryo Yamada
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 16, 2005
[Identification of disease-susceptible genes of rheumatic diseases]Ryo Yamada
Nature Clinical Practice. Rheumatology|March 6, 2008
Primer: SNP-associated studies and what they can teach usRyo Yamada
The New England Journal of Medicine|September 7, 2007
Lessons from a genomewide association study of rheumatoid arthritisKazuhiko Yamamoto, Ryo Yamada
Journal of Physics. Condensed Matter : an Institute of Physics Journal|January 15, 2020
Origin of the phase separation into B2 and L2<sub>1</sub> ordered phases in X-Al-Ti (X: Fe, Co, and Ni) alloys based on the first-principles cluster variation methodRyo Yamada, Tetsuo Mohri
Peerj|October 4, 2018
In silico study of medical decision-making for rare diseases: heterogeneity of decision-makers in a population improves overall benefitJuan Wang, Ryo Yamada
Journal of Autoimmunity|November 8, 2005
Genome-wide single nucleotide polymorphism analyses of rheumatoid arthritisKazuhiko Yamamoto, Ryo Yamada
Kidney International|November 22, 2021
Unexpected cause of vemurafenib-induced nephrotoxicity: ferrochelataseRyo Yamada, Motoko Yanagita
Pageof 26

Showing results (1-10 of 254) with videos related to

Sort By:
Pageof 26
Autoimmunity Reviews|May 17, 2005
Peptidylarginine deiminase type 4, anticitrullinated peptide antibodies, and rheumatoid arthritisRyo Yamada
Clinical Calcium|October 30, 2012
[Genomic approach to pathophysiology of rheumatoid arthritis]Ryo Yamada
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 1, 2005
[Susceptibility genes in rheumatoid arthritis: peptidylarginine deiminase (PADI) type 4]Ryo Yamada
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 16, 2005
[Identification of disease-susceptible genes of rheumatic diseases]Ryo Yamada
Nature Clinical Practice. Rheumatology|March 6, 2008
Primer: SNP-associated studies and what they can teach usRyo Yamada
The New England Journal of Medicine|September 7, 2007
Lessons from a genomewide association study of rheumatoid arthritisKazuhiko Yamamoto, Ryo Yamada
Journal of Physics. Condensed Matter : an Institute of Physics Journal|January 15, 2020
Origin of the phase separation into B2 and L2<sub>1</sub> ordered phases in X-Al-Ti (X: Fe, Co, and Ni) alloys based on the first-principles cluster variation methodRyo Yamada, Tetsuo Mohri
Peerj|October 4, 2018
In silico study of medical decision-making for rare diseases: heterogeneity of decision-makers in a population improves overall benefitJuan Wang, Ryo Yamada
Journal of Autoimmunity|November 8, 2005
Genome-wide single nucleotide polymorphism analyses of rheumatoid arthritisKazuhiko Yamamoto, Ryo Yamada
Kidney International|November 22, 2021
Unexpected cause of vemurafenib-induced nephrotoxicity: ferrochelataseRyo Yamada, Motoko Yanagita
Pageof 26